Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia.
dc.contributor.author | Shah, Siddharth N | en_US |
dc.contributor.author | , | en_US |
dc.date.accessioned | 2003-09-09 | en_US |
dc.date.accessioned | 2009-05-30T23:56:22Z | |
dc.date.available | 2003-09-09 | en_US |
dc.date.available | 2009-05-30T23:56:22Z | |
dc.date.issued | 2003-09-09 | en_US |
dc.description.abstract | AIMS OF THE STUDY: Asthenic symptoms such as weakness accompany illness. This study investigates whether the centrally acting cholinergic agent, vitamin B analogue (sulbutiamine), is effective and acceptable in relieving these symptoms in infectious disease when combined with specific anti-infective treatment. METHODOLOGY: In a prospective uncontrolled, non-randomised, commercial, observational study, 1772 patients with an infectious disease and asthenic symptoms, drawn from the practice of 350 randomly selected physicians throughout India, received vitamin B analogue (sulbutiamine) in addition to specific anti-infective treatment for 15 days. The primary outcome variable was complete resolution of asthenic symptoms with treatment. RESULTS: The number (%, 95% confidence interval) of patients with complete resolution of all asthenic symptoms was 916 (51.7, 49.4-54). In the remaining patients, severe asthenia was reduced but persisted in 11 (0.6, 0-26); and moderate asthenia in 94 (5.3, 0-17.6). The response was greater in patients with acute infection and symptoms more related to cerebral function. Side effects occurred in 10 (0.6%), patients and well being improved significantly. CONCLUSIONS: Vitamin B analogue (sulbutiamine) may be a useful adjunct to specific anti-infective treatment. | en_US |
dc.description.affiliation | SL Raheja Hospital, Bombay Mutual Terrace, Mumbai. | en_US |
dc.identifier.citation | Shah SN, . Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia. Journal of the Association of Physicians of India. 2003 Sep; 51(): 891-5 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/90867 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Asthenia --classification | en_US |
dc.subject.mesh | Confidence Intervals | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | India | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Severity of Illness Index | en_US |
dc.subject.mesh | Thiamine --analogs & derivatives | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.title | Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1